Ticker Report Shares of Revelation Biosciences, Inc. (NASDAQ:REVB - Get Free Report) were down 6.7% during mid-day trading on Wednesday . The company traded as low as $0.94 and last traded at $0.99. Approximately...\n more…
SeekingAlpha.com: All News Revelation Biosciences (REVB) files preliminary prospectus for resale of up to 5.1M shares of common stock by selling stockholders.\n more…
Seeking Alpha - Healthcare Revelation Biosciences announces exercise of warrants for $3.8M in gross proceeds...\n more…
Business Wire Revelation Biosciences Inc. (NASDAQ: REVB) (the Company or Revelation), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of...\n more…